Presentation is loading. Please wait.

Presentation is loading. Please wait.

Metabolic Syndrome By: Dr.AP.Ahmed el-Shaer Dr.Mohamed El-Zayat.

Published byRalf Robbins Modified over 9 years ago

Similar presentations

Presentation on theme: "Metabolic Syndrome By: Dr.AP.Ahmed el-Shaer Dr.Mohamed El-Zayat."— Presentation transcript:

1 Metabolic Syndrome By: Dr.AP.Ahmed el-Shaer Dr.Mohamed El-Zayat

2 Definition :

3 Pathophysiology of Metabolic Syndrome 1-Central (Visceral) Obesity 2-Insulin Resistance 3-Atherogenic Dyslipidemia 4-Hypertension 5-Thrombogenicity 6-Inflammation and Endothelial Dysfunction

4 Systemic Effects of Metabolic Syndrome Diabetes Acute stroke in the elderly. kidney Liver Pregnancy Surgical patient

5 Insulin Resistance

6 Strategies for Metabolic Management -Insulin Resistance and Hyperglycemia: A) Insulin secretagogues Sulfonylureas Nonsulfonylureas (repaglinide and nateglinide) B)Insulin-sensitizing agents Biguanides (metformin) PPAR- ligands (thiazolidinediones) -Atherogenic Dyslipidemia: HMG-CoA reductase inhibitors (statins) PPAR- ligands (fibrates) -Increased Blood Pressure: Inhibitors of the renin – angiotensin system B-Blockers Calcium channel antagonists

7 Exercise and Mobilization Nutrition

8 Anesthesia and Analgesia Volatile anesthetics Intravenous induction agents Opioids Neuraxial blockade

9 Thank you

Download ppt "Metabolic Syndrome By: Dr.AP.Ahmed el-Shaer Dr.Mohamed El-Zayat."

Similar presentations

Oral Hypoglycemic Drugs And Classifications

Oral Hypoglycemic Drugs And Classifications
M ETABOLIC S YNDROME IN P ERIONIAL D IALYSIS Dr. Sreelatha Calicut.

M ETABOLIC S YNDROME IN P ERIONIAL D IALYSIS Dr. Sreelatha Calicut.
Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Effect of renin-angiotensin system blockade on calcium.

Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Effect of renin-angiotensin system blockade on calcium.
Managing T2DM during Ramadan Dr. Asrar Said Hashem Specialist in Internal Medicine (Al-Amiri Hospital) Fellow of KIMS Endocrine, Diabetes and Metabolism.

Managing T2DM during Ramadan Dr. Asrar Said Hashem Specialist in Internal Medicine (Al-Amiri Hospital) Fellow of KIMS Endocrine, Diabetes and Metabolism.
DO YOU HAVE THE METABOLIC SYNDROME? You're never too young to have it Jacqueline A. Eberstein, R.N.

DO YOU HAVE THE METABOLIC SYNDROME? You're never too young to have it Jacqueline A. Eberstein, R.N.
Metabolic Syndrome Symposium Dar Al-Kalima Health and Wellness Center Bethlehem, Palestine Oct. 2005.

Metabolic Syndrome Symposium Dar Al-Kalima Health and Wellness Center Bethlehem, Palestine Oct
Metabolic Complications of HIV Dr Lou Haenel, Jr Endocrinology 12/10.

Metabolic Complications of HIV Dr Lou Haenel, Jr Endocrinology 12/10.
Hypertension – Summary

Hypertension – Summary
Antidiabetic Drugs Until 1994, FDA-approved antidiabetics Insulin and Sulfonylurea Last few years, the list was expanding Insulin (different preparations.

Antidiabetic Drugs Until 1994, FDA-approved antidiabetics Insulin and Sulfonylurea Last few years, the list was expanding Insulin (different preparations.
Type 2 Diabetes Mellitus Aetiology, Pathogenesis, History, and Treatment.

Type 2 Diabetes Mellitus Aetiology, Pathogenesis, History, and Treatment.
T2DM MANAGEMENT DENTAL COURSE 2010 2011 Mohamed AlMaatouq, MD King Khalid University Hospital King Saud University.

T2DM MANAGEMENT DENTAL COURSE Mohamed AlMaatouq, MD King Khalid University Hospital King Saud University.
Linked Metabolic Abnormalities:

Linked Metabolic Abnormalities:
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?

Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Diabetes Mellitus Dr. Meg-angela Christi Amores. Diabetes Mellitus refers to a group of common metabolic disorders that share the phenotype of hyperglycemia.

Diabetes Mellitus Dr. Meg-angela Christi Amores. Diabetes Mellitus refers to a group of common metabolic disorders that share the phenotype of hyperglycemia.
LONG TERM BENEFITS OF ORAL AGENTS

LONG TERM BENEFITS OF ORAL AGENTS
M ETABOLIC S YNDROME By Dr. Sumbul Fatma Clinical Chemistry Unit Department of Pathology.

M ETABOLIC S YNDROME By Dr. Sumbul Fatma Clinical Chemistry Unit Department of Pathology.
Management of Dyslipidemia in Patients with Peripheral Arterial Disease: an update from Guidelines Oman International Vascular Conference Al-Bustan Palace.

Management of Dyslipidemia in Patients with Peripheral Arterial Disease: an update from Guidelines Oman International Vascular Conference Al-Bustan Palace.
DIABETES MELLITUS THERAPY. Nutrition Therapy  Weight loss frequently is a primary goal of nutrition therapy because 80% to 90% of people with type II.

DIABETES MELLITUS THERAPY. Nutrition Therapy  Weight loss frequently is a primary goal of nutrition therapy because 80% to 90% of people with type II.
METABOLIC Syndrome: a Global Perspective

METABOLIC Syndrome: a Global Perspective
Criteria for Diagnosis of DM * Testing must be repeated on separate day. FPG is the preferred test ** Symptoms of DM IFG = Impaired fasting glucose IGT.

Criteria for Diagnosis of DM * Testing must be repeated on separate day. FPG is the preferred test ** Symptoms of DM IFG = Impaired fasting glucose IGT.

Similar presentations

Ads by Google